BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6275252)

  • 1. Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.
    Gergely L; Gzeglédy J; Váczi L
    Med Microbiol Immunol; 1981; 170(2):99-108. PubMed ID: 6275252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
    Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
    Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
    Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
    Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
    Schmitz H; Kampa D; Heidenreich W
    Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J; Tamarit A; Igual R; Navarro D
    J Clin Virol; 2000 Apr; 16(2):113-22. PubMed ID: 10720815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the presence of antibodies to EB virus and other herpesviruses in normal children and in infectious mononucleosis.
    Gergely L; Czeglédy J; Váczi L; Szabó B; Binder L; Szalka A
    Acta Microbiol Acad Sci Hung; 1975; 22(2):75-82. PubMed ID: 164758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB; Pope JH; Hazelton RA
    Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.
    Navalpotro D; Gimeno C; Navarro D
    J Clin Virol; 2006 Feb; 35(2):193-6. PubMed ID: 16125456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious mononucleosis. Determination of immunofluorescent antibodies against the Epstein-Barr virus and complement-fixation antibodies against the cytomegalovirus].
    Lasovská J; Kouba K; Sobĕslavský O; Seeman J; Moravcová E; Kucharská Z; Vojtĕchovský K
    Cas Lek Cesk; 1973 Jan; 112(2):38-42. PubMed ID: 4345614
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus in the mononucleosis syndrome in children.
    Najberg G; Jankowski M; Krotochwil-Skrzypkowa M; Gut W
    Acta Microbiol Pol; 1985; 34(2):137-44. PubMed ID: 2412401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serodiagnosis of infectious mononucleosis in children.
    Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
    Acta Paediatr Jpn; 1998 Aug; 40(4):328-32. PubMed ID: 9745774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T; Sullivan JL; Humphreys RE
    J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.